Opening of Bids - Gemini at Washington-Colfax Apartments - Project No 118-080B - Pauls Welding Inc - Bid Security Chk Submitted

Home Browse Search

(i} Failure to appear or remain at the test site. (ii) Failure to provide urine specimen when required. (iii) Failure to permit direct observation or monitored collection. (iv) Declines to take a second test when directed. (v) Failure to provide sufficient urine or breath without a valid medical explanation. (vi) Failure to undergo a medical evaluation. (vii) Failure to cooperate with the testing process. (viii) Attempt to dilute, substitute, or tamper with a specimen. (ix) Failure to sign the Custody Control Form or Breath Alcohol Form. H. Testing Procedures Federal regulations required analytical urine drug testing and breath alcohol testing to be conducted when circumstances warrant or as outlined in the regulations. Paul's Welding Inc affirms the need to protect individual dignity, privacy, and confidentiality throughout the testing process. If at any time the integrity of the testing procedures or the validity of the tests results are compromised, the test will be cancelled. Drug _Tests The drugs that will be tested for include marijuana (THC), cocaine, opiates, amphetamines, and phencyclidine (PCP). Urine specimens will be conducted using the split specimen sample method as described in 49 CFR Part 40. Each specimen will be accompanied by a DOT Chain of Custody and Control Form (CCF) and identified using a unique identification number that attributes the specimen to the correct individual. The specimen will be sent to a laboratory where a validity test will be performed to ensure that it is non -adulterated human urine. Then an initial drug screen test will be conducted on the primary specimen. For the primary specimen that is not negative, a confirmatory Gas Chromatography/Mass Spectrometry (GC/MS) test will be performed. The primary test will be considered positive if the amounts present are above the minimum thresholds established in 49 CFR Part 40. All test results from the laboratory will be reported to a Medical Review Officer (MRO). The MRO is a licensed physician with detailed knowledge of substance abuse disorders and drug testing. The MRO will be knowledgeable in the DOT regulations and MRO guidelines, DOT operating administration regulations and any changes to any of these. The MRO must obtain the appropriate qualification training as mandated in 49 CFR Part 40. The MRO will review all test results to ensure the scientific validity of the test and to determine whether there is a legitimate medical explanation for a confirmed positive test result. The MRO will contact the employee, notify him/her of the positive laboratory result, and provide the employee with an opportunity to 0